Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Non Operating Income (2016)

Viking Therapeutics' (VKTX) quarterly Non Operating Income came in at -$64514.0 in Q3 2016.

Analysis

Viking Therapeutics (VKTX) Non Operating Income (2016) Analysis & Trends

Viking Therapeutics has disclosed Non Operating Income across 1 years of filings, most recently posting -$64514.0 for Q3 2016.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 387.00 Mn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Viking Therapeutics 4.86 Bn 4.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -64,514.00
API Access

Viking Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=VKTX&period=max&api_key=YOUR_API_KEY